Preparation and characterization of the 'research chemical' diphenidine, its pyrrolidine analogue, and their 2, 2‐diphenylethyl isomers. Issue 5 (15th July 2014)

• Record Type: Journal Article
• Authors: Wallach, Jason; Kavanagh, Pierce V.; McLaughlin, Gavin; Morris, Noreen; Power, John D.; Elliott, Simon P.; Mercier, Marion S.; Lodge, David; Morris, Hamilton; Dempster, Nicola M.; Brandt, Simon D.
• Is Part Of: Drug testing and analysis. Volume 7:Issue 5(2015:May)
• Page Start: 358
• Page End: 367
• Publication Date: 2014-07-15
• Subjects: Drugs -- Analysis -- Periodicals; Drug testing -- Periodicals; Chemistry, Forensic -- Periodicals; 615.1901
• DOI: 10.1002/dta.1689
• Languages: English
• ISSNs: 1942-7603

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Substances with the diphenylethylamine nucleus represent a recent addition to the product catalog of dissociative agents sold as 'research chemicals' on the Internet. Diphenidine, i.e. 1‐(1, 2‐diphenylethyl)piperidine (1, 2‐DEP), is such an example but detailed analytical data are less abundant. The present study describes the synthesis of diphenidine and its most obvious isomer, 1‐(2, 2‐diphenylethyl)piperidine (2, 2‐DEP), in order to assess the ability to differentiate between them. Preparation and characterization were also extended to the two corresponding pyrrolidine analogues 1‐(1, 2‐diphenylethyl)‐ and 1‐(2, 2‐diphenylethyl)pyrrolidine, respectively. Analytical characterizations included high‐resolution electrospray mass spectrometry (HR‐ESI‐MS), liquid chromatography ESI‐MS/MS, gas chromatography ion trap electron and chemical ionization MS, nuclear magnetic resonance spectroscopy (NMR) and infrared spectroscopy. Differentiation between the two isomeric pairs was possible under GC‐(EI/CI)‐MS conditions and included the formation of distinct iminium ions, such as <italic>m/z</italic> 174 for 1, 2‐DEP and <italic>m/z</italic> 98 for 2, 2‐DEP, respectively. The pyrrolidine counterparts demonstrated similar phenomena including the expected mass difference of 14 Da due to the lack of one methylene unit in the ring. Two samples obtained from an Internet vendor provided confirmation that diphenidine was present in both samples, concurring with the product label. Finally, it was confirmed that diphenidine (30 μM) reduced <italic>N</italic>‐methyl‐<sc>D</sc>‐aspartate‐mediated field excitatory postsynaptic potentials (NMDA‐fEPSPs) to a similar extent to that of ketamine (30 μM) when using rat hippocampal slices. The appearance of 1, 2‐ diphenylethylamines appears to reflect the exploration of alternatives to arylcyclohexylamine‐type substances, such as methoxetamine, PCP and PCPy‐based analogues that also show NMDA receptor activity as demonstrated here for diphenidine. Copyright © 2014 John Wiley & Sons, Ltd.</p> </abstract>